The company is responsible for ensuring that data collection and analysis takes place. They must confirm that agreements are in place to generate the evidence. NICE will contact the company annually ...
Disclosure: The author declares no conflicts of interest. Keywords: AI, COPD, CT phenotyping, digital health technologies, eosinophilic COPD, mepolizumab, precision ...
一部の結果でアクセス不可の可能性があるため、非表示になっています。
アクセス不可の結果を表示する